Bill

Bill > HB137


PA HB137

PA HB137
Further providing for drug overdose response immunity.


summary

Introduced
01/28/2019
In Committee
12/26/2019
Crossed Over
12/17/2019
Passed
Dead
12/31/2020

Introduced Session

2019-2020 Regular Session

Bill Summary

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

AI Summary

This bill amends the Controlled Substance, Drug, Device and Cosmetic Act to further provide for drug overdose response immunity. Specifically, it states that a person experiencing a drug overdose event may not be charged and shall be immune from prosecution if, within 10 days of receiving medical attention, they obtain a screening and referral for treatment from an accredited addiction services provider. Additionally, a person who transported or reported and remained with someone experiencing a drug overdose event may not be charged and is entitled to immunity, but only if the person experiencing the overdose obtains the required screening and referral within 30 days of receiving written notice. The bill also requires law enforcement or the courts to provide written notice of these requirements to the person experiencing the overdose.

Committee Categories

Budget and Finance, Justice

Sponsors (15)

Last Action

Referred to JUDICIARY (on 12/26/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...